Our Research and Development is focused on developing new and innovative tests for diagnosis for cancer and CNS disorders.
For cancer we are working on developing a liquid Biopsy assay for Breast cancer diagnosis and monitoring of treatment response. Our research is also focused on performing RNA sequencing to identify the different BC subtypes using liquid biopsy.
In CNS our research is focused on developing new and innovative tests for diagnosis of neurodegenerative disorders.
We are also specialized in genetic testing in oncology and CNS clinical trials.